Q-Linea AB

Q-Linea AB, a Swedish diagnostics company, has announced a SEK 322 million rights issue to accelerate its growth and reach a break-even point by 2027, with the funds to be used for product development, manufacturing, and strengthening its balance sh…

Q-Linea AB, a Swedish company specializing in in vitro diagnostics, has undergone a significant corporate restructuring, including a reverse stock split, in an effort to stabilize its stock price and enhance its market perception.

Q-Linea AB, a Swedish health care equipment company, reports improved revenue and prospects for achieving its placement target, despite ongoing financial challenges.

Q-Linea AB has announced a reverse share split, combining 1,000 existing shares into one new share, to streamline its share distribution and potentially enhance market perception and liquidity.